Search by Drug Name or NDC

    NDC 00781-1683-01 Cetirizine Hydrochloride 5 mg/1 Details

    Cetirizine Hydrochloride 5 mg/1

    Cetirizine Hydrochloride is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is CETIRIZINE HYDROCHLORIDE.

    Product Information

    NDC 00781-1683
    Product ID 0781-1683_1f37dec7-beb5-4add-84de-b49b69766b3e
    Associated GPIs 41550020100310
    GCN Sequence Number 024484
    GCN Sequence Number Description cetirizine HCl TABLET 5 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 49292
    HICL Sequence Number 006544
    HICL Sequence Number Description CETIRIZINE HCL
    Brand/Generic Generic
    Proprietary Name Cetirizine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cetirizine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name CETIRIZINE HYDROCHLORIDE
    Labeler Name Sandoz Inc
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077946
    Listing Certified Through 2024-12-31

    Package

    NDC 00781-1683-01 (00781168301)

    NDC Package Code 0781-1683-01
    Billing NDC 00781168301
    Package 100 TABLET in 1 BOTTLE (0781-1683-01)
    Marketing Start Date 2007-12-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 22d8e474-e611-4815-b484-86d7c69cd6f9 Details

    Revised: 6/2013